Synthesis and characterization of glucosulfonic acid supported on Fe3O4 nanoparticles as a novel and magnetically recoverable nanocatalyst and its application in the synthesis of polyhydroquinoline and 2,3-dihydroquinazolin-4(1H)-one derivatives

Maryam Hajjami* and Bahman Tahmasbi
Department of Chemistry, Faculty of Science, Ilam University, Ilam, Iran. E-mail: mhajjjami@yahoo.com; Fax: +988412227022; Tel: +988412227022

Received 13th May 2015 , Accepted 25th June 2015

First published on 25th June 2015


Abstract

Glucosulfonic acid immobilized on Fe3O4 magnetic nanoparticles (GSA@MNPs) have been reported as an efficient and magnetically reusable nanocatalyst for the clean and one-pot synthesis of polyhydroquinoline and 2,3-dihydroquinazolin-4(1H)-one derivatives, with short reaction times in good to high yields in ethanol. After completing the reactions the catalyst was easily separated from the reaction mixture using an external magnetic field and reused for several consecutive runs without significant loss of catalytic efficiency. This new catalyst was characterized using FT-IR spectroscopy, TGA, XRD, VSM, TEM, EDS and SEM.


1. Introduction

The immobilization of homogeneous catalysts on various support materials, such as organic polymers and inorganic silica and other metal oxides, to combine the advantages of both homogeneous and heterogeneous catalysis have been widely used as useful recoverable and reusable catalysts for organic synthesis.1 Nanoparticulate supports can be used to efficiently bridge the gap between homogeneous and heterogeneous catalysis.2 However, the supported nanocatalyst may need to be isolated from the products using difficult, time consuming and expensive conventional techniques, such as filtration or centrifugation.3 This drawback can be overcome by using magnetic nanoparticles (MNPs), which can be easily and rapidly separated from the reaction mixture with the assistance of an external magnet.4 Magnetic nanoparticles are a highly favourable material for the attachment of homogeneous inorganic and organic containing catalysts.5 More importantly, magnetic separation of the MNPs is more effective and easier than filtration or centrifugation, and is a simple, economical, and clean separation method that is promising for industrial applications.6–8 One of the most promising MNP supports for the development of high performance catalyst supports is superparamagnetic iron oxide.9 The notable advantages of Fe3O4 NPs are simple synthesis, ready availability, low cost, high surface area, low toxicity, operational simplicity and much easier and more effective separation than filtration or centrifugation.10 Therefore, Fe3O4 NPs are considered as ideal supports for the heterogenization of homogeneous catalysts.11 The outstanding potential of Fe3O4 nanoparticles has stimulated the extensive development of synthetic technologies, which can be broadly classified. Among them, the chemical coprecipitation method for preparation of Fe3O4 is very simple and efficient.12 However, many supports, such as mesoporous silica or nanoparticles, require high temperature for calcination and a lot of time and tedious conditions to prepare.13–16

The large active surface area of magnetic nanoparticles and their superparamagnetic properties leads to the agglomeration of the bare nanoparticles of iron oxides. Therefore, coating the catalyst surface with an organic or inorganic shell is an appropriate strategy to prevent agglomeration.17 More importantly, an organic coat over the iron nano-core imparts various desirable properties, such as thermal and chemical stability, high mechanical tolerance and ease of functionalization.18 On the other hand, terminal amine or hydroxyl groups in the extrinsic surface layers can be functionalized to convert a homogeneous catalyst into a heterogeneous catalytic system. In recent years, impressive efforts have been made in the development of new catalytic systems which are immobilized onto Fe3O4.19–25

Polyhydroquinoline and 2,3-dihydroquinazolinone derivatives are very well-known molecules that include a six-membered heterocyclic ring, which have been reported to possess a wide range of biological properties and pharmaceutical activities.9,10 Polyhydroquinoline (PHQ) derivatives contain a large family of medicinally important compounds that have attracted much attention because of their diverse pharmacological and therapeutic properties, such as vasodilator, hepatoprotective, antiatherosclerotic, bronchodilator, antitumor, geroprotective and antidiabetic activities, and also their ability to modulate calcium channels.26,27 Thus, the synthesis of these heterocycles has become an area of great interest. Also, 2,3-dihydro-4(1H)-quinazolinones are important bicyclic heterocycles which have emerged as versatile biologically active compounds possessing applications as diuretic, vasodilating, tranquilizing, antitumor, antidefibrillatory, antibiotic, antihistaminic, anticonvulsant, anticancer, herbicidal, plant growth regulation and antihypertensive agents.4,10,28 They are also reported to possess the ability to inhibit enzymes of biological importance.29 In addition, these compounds can be easily oxidized to their quinazolin-4(3H)-one analogues,10 which also include important pharmacologically active compounds. Generally, 2,3-dihydroquinazolin-4(1H)-ones are prepared using the reductive cyclization of aldehydes or ketones with 2-aminobenzamide in the presence of acid catalysts.9,29

For these reasons, many methods have been developed, including microwave and ultrasound irradiation techniques using various catalytic systems.26–29 However, most of these processes suffer from one or several drawbacks, such as longer reaction time, tedious workup, harsh reaction conditions, unsatisfactory yields, and the use of a large quantity of environmentally toxic and expensive catalysts. On the other hand, the toxicity of magnetic glyconanoparticles has been investigated and they have been revealed to be non-toxic at high concentration, and this is safe and positive from the point of view of the environment and green chemistry.30

In addition, some of these catalysts cannot be recovered and reused again. Thus, there is a necessity to develop a simple and efficient method for the synthesis of polyhydroquinolines and 2,3-dihydroquinazolin-4(1H)-ones in high yields under mild reaction conditions.

2. Results and discussion

2.1. Catalyst preparation

In continuation of our studies,31 herein we report a simple and efficient method for the synthesis of polyhydroquinolines and 2,3-dihydroquinazolin-4(1H)-ones in the presence of catalytic amounts of GSA@MNPs in ethanol under reflux conditions. The details of the preparation procedure of the supported catalyst are presented in Scheme 1. Initially, the magnetic core of Fe3O4 nanoparticles has been prepared by a chemical coprecipitation technique using FeCl3·6H2O and FeCl2·6H2O in basic solution at 80 °C.4,9 Ultimately, after coating the Fe3O4 nanoparticles with gluconic acid solution, the functionalization of the facial hydroxyl groups with chlorosulfonic acid led to supported glucosulfonic acid on Fe3O4 nanoparticles (GSA@MNPs).
image file: c5ra08952b-s1.tif
Scheme 1 Synthesis of GSA@MNPs.

2.2. Catalyst characterization

The catalyst has been characterized using transmission electron microscopy (TEM), scanning electron microscopy (SEM), energy-dispersive X-ray spectroscopy (EDS), X-ray diffraction (XRD), thermogravimetric analysis (TGA), Fourier transform infrared spectroscopy (FT-IR) and a Vibrating Sample Magnetometer (VSM).

The morphology and size of the catalyst was evaluated using scanning electron microscopy and transmission electron microscopy. It can be seen that most of the particles are quasi-spherical with an average diameter of about 10 nm (Fig. 1). To investigate the catalyst characterization state of the supported sulfonic acid species, the synthesized catalyst was analyzed using EDS. As shown in Fig. 2, the EDS spectrum of the catalyst showed the presence of S, O and C species in the catalyst (Fig. 2).


image file: c5ra08952b-f1.tif
Fig. 1 TEM (a and b) and SEM (c) images of GSA@MNPs.

image file: c5ra08952b-f2.tif
Fig. 2 EDS spectrum of GSA@MNPs.

The formation of a magnetite crystal phase in the glucosulfonic acid-coated Fe3O4 aggregate powder was identified from the X-ray diffraction pattern (Fig. 3). As seen in Fig. 3, the iron oxide phase was identified from the XRD patterns by the peak positions at 30.2 (2 2 0), 35.5 (3 1 1), 43.0 (4 0 0), 57.1 (5 1 1) and 62.9 (4 4 0), which were in agreement with the standard data of magnetite.32


image file: c5ra08952b-f3.tif
Fig. 3 The XRD pattern of GSA@MNPs.

One indication of the bond formation between the Fe3O4 and the catalyst can be inferred from thermogravimetric analysis (TGA). Fig. 4 shows the TGA curves for bare Fe3O4 nanoparticles (blue curve), gluconic acid-coated nanoparticles (red curve) and the catalyst-treated nanoparticles (green curve). The magnetite-only curve reveals little in terms of mass loss. Loss of strongly adsorbed water and dehydration of surface hydroxy groups occurs at approximately 250 °C. The weight loss at temperatures below 200 °C is due to the removal of physically adsorbed solvent and surface hydroxyl groups. The weight loss of about 2% between 260 and 350 °C may be associated with the thermal crystal phase transformation from Fe3O4 to γ-Fe2O3 (ref. 33) and decomposition of sulfonic acid and formation of sulfur dioxide.34 Organic groups have been reported to desorb at temperatures above 260 °C. The gluconic acid-coated magnetite nanoparticles (GA@MNPs) are found to show a mass percentage loss of about 12%, while the catalyst-loaded particles have the greatest mass loss, at 28%.


image file: c5ra08952b-f4.tif
Fig. 4 TGA diagram of (blue line) Fe3O4 NPs, (red line) GA@MNPs and (green line) GSA@MNPs.

Successful functionalization of the Fe3O4 NPs can be inferred using the FT-IR technique. The FT-IR spectrum of the GSA@MNPs shows several peaks that are characteristic of a functionalized glucosulfonic acid, which clearly differs from those of the unfunctionalized Fe3O4 nanomagnets and GA@MNPs nanoparticles (Fig. 5). The FT-IR spectrum for the Fe3O4 alone shows a stretching vibration at 3420 cm−1 which incorporates the contributions from both symmetrical and asymmetrical modes of the O–H bonds that are attached to the surface of the magnetic nanoparticles. The strong bands at low wavenumbers (≤700 cm−1) come from the vibrations of the Fe–O bonds of iron oxide.4 The presence of an adsorbed water layer is confirmed by a stretch for the vibrational mode of water found at 1631 cm−1. In the FT-IR spectrum of the GA@MNPs, the presence of the anchored glucosulfonic acid group is confirmed by C–H stretching vibrations that appear at 2970 and 2850 cm−1 and also O–H stretching vibration modes as a broad band that appears at 3400 cm−1. Reaction of the GA@MNPs with chlorosufonic acid produces GSA@MNPs in which the presence of the SO3H moiety is asserted by 998–1220 cm−1 bands in the FT-IR spectrum. Also, vibrations in the range of 2850–3500 cm−1 are attributed to the terminal acidic groups. In addition, in the spectrum of the GSA@MNPs the peak at 3405 cm−1, which is overlapped by the C–H stretching vibration, is probably attributable to the SO3–H groups.9 All of these bands reveal that the surface of the Fe3O4 nanoparticles is successfully modified with glucosulfonic acid.


image file: c5ra08952b-f5.tif
Fig. 5 FT-IR spectra of (a) Fe3O4 NPs, (b) GA@MNPs and (c) GSA@MNPs.

As superparamagnetic particles are beneficial for magnetic separation, the magnetic properties of the MNPs and GSA@MNPs were characterized using a VSM. The room temperature magnetization curves of the GSA@MNPs are shown in Fig. 6. The magnetic measurements show that the GSA@MNPs have a saturated magnetization value of 49 emu g−1.


image file: c5ra08952b-f6.tif
Fig. 6 Magnetization curve for GSA@MNPs at room temperature.

2.3. Catalytic study

As a part of our ongoing program directed towards the development of new methods for the catalytic activity of GSA@MNPs in organic reactions, we were interested in finding a simple and efficient method for the one-pot synthesis of polyhydroquinoline derivatives using magnetic nanoparticles bonded to glucosulfonic acid (GSA@MNPs) as a magnetically recoverable nanocatalyst in ethanol (Scheme 2).
image file: c5ra08952b-s2.tif
Scheme 2 GSA@MNPs catalyzed the one-pot synthesis of polyhydroquinoline derivatives.

The reaction conditions for the one-pot synthesis of polyhydroquinoline derivatives was optimized from the reaction of 4-chlorobenzaldehyde with dimedone, ammonium acetate and ethylacetoacetate under the influence of different amounts of GSA@MNPs in ethanol as a model reaction (Table 1). It is noteworthy that only 50% of the desired product was isolated using a TLC plate in the absence of the catalyst after 200 min at 80 °C (Table 1, entry 1). As shown in Table 1, 4-chlorobenzaldehyde (1 mmol), dimedone (1 mmol), ethylacetoacetate (1 mmol) and ammonium acetate (1.2 mmol) in the presence of a catalytic amount of GSA@MNPs (0.05 g) in ethanol under reflux conditions were found to be the ideal reaction conditions for the one-pot synthesis of polyhydroquinoline derivatives.

Table 1 Optimization of the conditions for synthesis of polyhydroquinolines via the condensation of 4-chlorobenzaldehyde, dimedone, ethylacetoacetate and ammonium acetate as a model reaction in ethanol for 200 min
Entry Catalyst (mg) Temperature (°C) Yielda (%)
a Isolated yield.
1 80 41
2 0.02 80 54
3 0.03 80 61
4 0.04 80 77
5 0.05 80 94
6 0.05 60 67
7 0.05 Trace


The reaction of various benzaldehyde derivatives, including electron-donating and electron-withdrawing groups on the aromatic ring, with dimedone, ethylacetoacetate and ammonium acetate was then investigated to confirm the generality of the present method. The polyhydroquinoline derivatives were obtained in high yields. The results of this study are summarized in Table 2. The effect of the substitution present on the aromatic aldehyde on the reaction rate and the overall yield was also studied. As shown, a variety of benzaldehydes bearing electron-donating (Table 2, entries 2–6) and electron-withdrawing (Table 2, entries 7–10) substituents were successfully employed to prepare the corresponding polyhydroquinoline derivatives in excellent yields.

Table 2 Synthesis of polyhydroquinolines catalyzed by GSA@MNPs in ethanol at 80 °C
Entry Product Time (min) Yielda (%) Melting point (°C) Ref.
a Isolated yield.
1 image file: c5ra08952b-u1.tif 240 90 218–220 36
2 image file: c5ra08952b-u2.tif 250 92 176–179 9
3 image file: c5ra08952b-u3.tif 260 89 252–254 9
4 image file: c5ra08952b-u4.tif 200 88 230–232 36
5 image file: c5ra08952b-u5.tif 250 94 249–250 9
6 image file: c5ra08952b-u6.tif 200 88 204–205 35
7 image file: c5ra08952b-u7.tif 300 80 176–178 27
8 image file: c5ra08952b-u8.tif 280 91 251–252 9
9 image file: c5ra08952b-u9.tif 210 93 184–186 9
10 image file: c5ra08952b-u10.tif 200 94 238–239 35


The mechanism of this reaction is shown in Scheme 3.37 The role of the catalyst comes in the Knoevenagel-type coupling of the aldehydes with the active methylene compounds and in the Michael-type addition of the intermediates to give the final product.


image file: c5ra08952b-s3.tif
Scheme 3 The proposed mechanism of the synthesis polyhydroquinoline derivatives in the presence of GSA@MNPs.

In the second part of our study on the application of the catalytic activity of GSA@MNPs in organic synthesis, we were interested in finding a simple and efficient method for the synthesis of 2,3-dihydroquinazolin-4(1H)-one derivatives, under the influence of GSA@MNPs as a reusable nanocatalyst with short reaction times in good to excellent yields in ethanol under reflux conditions, using the cyclocondensation reaction of aldehydes and anthranilamide (Scheme 4).


image file: c5ra08952b-s4.tif
Scheme 4 GSA@MNPs catalyzed the synthesis of 2,3-dihydroquinazolin-4(1H)-one derivatives.

The reaction conditions for the synthesis of 2,3-dihydroquinazolin-4(1H)-one derivatives was optimized using the cyclocondensation reaction of anthranilamide (1 mmol) and 4-chlorobenzaldehyde (1 mmol) in ethanol in the presence of different amounts of GSA@MNPs as a model reaction over a wide range of temperatures (Table 3). As shown in Table 3, 4-chlorobenzaldehyde (1 mmol) in the presence of a catalytic amount of GSA@MNPs (0.01 g) in ethanol at 80 °C were found to be the ideal reaction conditions for the synthesis 2,3-dihydroquinazolin-4(1H)-ones. In order to show the activity of the GSA@MNPs, we carried out the cyclocondensation of 4-chlorobenzaldehyde with anthranilamide in the absence of catalyst, in which the reaction did not occur even after a prolonged reaction time (Table 3, entry 1).

Table 3 Optimization of the conditions for synthesis of 2,3-dihydroquinazolin-4(1H)-ones via the condensation of 4-chlorobenzaldehyde with anthranilamide as a model reaction in ethanol for 50 min
Entry Catalyst (g) Temperature (°C) Yielda (%)
a Isolated yield.b No reaction.
1 80 b
2 0.005 80 45
3 0.007 80 67
4 0.01 80 99
5 0.01 60 72
6 0.01 Trace


After the optimization of the reaction conditions, various aldehydes including several different functional groups were reacted under the optimum conditions and the corresponding 2,3-dihydroquinazolin-4(1H)-one compounds were obtained in good to excellent yields. The results of these studies are summarized in Table 4. As shown, a variety of benzaldehydes bearing electron-donating (Table 4, entries 2–6) and electron-withdrawing (Table 4, entries 7–10) substituents were successfully employed to prepare the corresponding 2,3-dihydroquinazolin-4(1H)-one derivatives in excellent yields. The experimental procedure is very simple and convenient, and has the ability to tolerate a variety of other functional groups, such as hydroxyl, halide, nitro, alkyl and alkoxy, under the reaction conditions.

Table 4 Synthesis of 2,3-dihydroquinazolin-4(1H)-ones catalyzed by GSA@MNPs in ethanol at 80 °C
Entry Product Time (min) Yielda (%) Melting point (°C) Ref.
a Isolated yield.
1 image file: c5ra08952b-u11.tif 55 90 221–223 4
2 image file: c5ra08952b-u12.tif 75 94 190–192 9
3 image file: c5ra08952b-u13.tif 25 96 275–278 10
4 image file: c5ra08952b-u14.tif 70 92 228–230 9
5 image file: c5ra08952b-u15.tif 75 93 167–169 4
6 image file: c5ra08952b-u16.tif 25 98 211–213 10
7 image file: c5ra08952b-u17.tif 35 99 197–199 10
8 image file: c5ra08952b-u18.tif 65 96 197–199 9
9 image file: c5ra08952b-u19.tif 50 99 202–204 4
10 image file: c5ra08952b-u20.tif 80 91 190–192 10


2.4. Comparison of the catalyst

To show the merit of glucosulfonic acid@Fe3O4 in comparison with other reported catalysts, we summarize several results for the preparation of 2-(4-chlorophenyl)-2,3-dihydoquinazolin-4(1H)-one from 4-chlorobenzaldehyde and anthranilamide in Table 5. It is obvious that the catalyst showed a good reaction time and higher yield than other catalysts used in the literature. Also, the new catalyst is comparable in terms of price, non-toxicity, stability and ease of separation.
Table 5 Comparison results of glucosulfonic acid@Fe3O4 with other catalysts for the reaction of anthranilamide and 4-chlorobenzaldehyde
Entry Catalyst (mol%) Time (min) Yield (%) Conditions [Ref.]
1 2-Morpholino ethanesulfonic acid (10) 180 89 Ethanol, 60 °C
12 92 Ethanol, MW (600 W) [ref. 38]
2 Propylphosphonic anhydride (0.5 mmol) 10 87 CH3CN, sealed tube [ref. 39]
3 [hnmp][HSO4] (5) 28 83 Solvent-free, 80 °C [ref. 40]
[NMP][HSO4] (5) 22 84
[NMP][H2PO4] (5) 38 79
4 [Bmim]PF6 (2 mL) 40 90 Ionic liquid, 75 °C [ref. 41]
5 Co–carbon nanotubes (0.008 g) 12 91 Solvent-free, rt [ref. 42]
6 H3PW12O40 (0.1) 10 90 H2O, rt [ref. 43]
7 Poly(4-vinylpyridine) supported acidic ionic liquid (0.2 g) 8 90 Ethanol, rt, ultrasonic irradiation [ref. 44]
8 β-Cyclodextrin-SO3H (0.1 mmol) 30 83 H2O, rt [ref. 45]
9 Citric acid (0.4 mmol), acidic Al2O3 (0.5 g) 15 85 Solvent-free, rt, grinding [ref. 46]
10 Glucosulfonic acid@Fe3O4 (0.01 g) 50 99 Ethanol, reflux [this work]


2.5. Recyclability of the catalyst

The GSA@MNPs, as a magnetically reusable nanocatalyst, can be easily recycled for repeated synthesis of polyhydroquinoline. For practical purposes the ability to easily recycle the catalyst is highly desirable. To investigate this issue, the recyclability of the catalyst was examined for the reaction of 4-chlorobenzaldehyde with dimedone, ethylacetoacetate and ammonium acetate as a model reaction in ethanol using 0.05 g of catalyst. We found that this catalyst demonstrated remarkably excellent reusability; after the completion of the reaction, the catalyst was easily and rapidly recovered from the reaction mixture using an external magnet. The remaining magnetic nanocatalyst was washed with ethanol to remove residual product and the reaction mixture decanted (Fig. 7). Then, the reaction vessel was charged with fresh 4-chlorobenzaldehyde, dimedone, ethylacetoacetate and ammonium acetate and subjected to the next run. As shown in Fig. 8, the catalyst was used over 6 runs without any significant loss of activity. The average isolated yield for 6 successive runs was 96%, which clearly demonstrates the practical recyclability of this catalyst. In addition, one of the attractive features of this novel catalyst system is the rapid (within 5 s) and efficient (100%) separation of the catalyst using an appropriate external magnet, which minimizes the loss of catalyst during separation.
image file: c5ra08952b-f7.tif
Fig. 7 Image showing that GSA@MNPs can be separated using an applied magnetic field. A reaction mixture in the absence (left) or presence (right) of a magnetic field.

image file: c5ra08952b-f8.tif
Fig. 8 The recycling experiment of GSA@MNPs in the condensation of 4-chlorobenzaldehyde, dimedone, ethylacetoacetate and ammonium acetate.

3. Conclusions

In summary, we have demonstrated that GSA@MNPs can be used as a green, efficient and reusable nanocatalyst for the synthesis of a wide range of polyhydroquinoline and 2,3-dihydroquinazolin-4(1H)-one derivatives in ethanol under reflux conditions. The advantages of these protocols are the use of commercially available, eco-friendly, cheap and chemically stabile materials, the operational simplicity, practicality and good to high yields. The product separation and catalyst recycling are easier and simpler with the assistance of an external magnet. The catalyst can be reused 6 times with little loss of activity.

4. Experimental

4.1. Preparation of the Fe3O4 magnetic nanoparticles

The free Fe3O4 NPs were prepared using chemical precipitation of Fe3+ and Fe2+ ions with a molar ratio of 2[thin space (1/6-em)]:[thin space (1/6-em)]1. Typically, FeCl3·6H2O (5.838 g, 0.0216 mol) and FeCl2·4H2O (2.147 g, 0.0108 mol) were dissolved in 100 mL deionized water at 80 °C under N2 atmosphere and vigorous mechanical stirring conditions. Then, 10 mL of 25% NH4OH was added to the reaction mixture. After 30 minutes, the reaction mixture was cooled to room temperature. After completion of the reaction, the nanoparticles (Fe3O4) were washed two times with distilled water and a 0.02 M solution of NaCl, and each time was decanted with an external magnet.

4.2. Preparation of magnetic nanoparticles bonded with gluconic acid (GA@MNPs)

The obtained Fe3O4 NPs (2 g) were dispersed in 15 mL water, and dissolved by sonication for 30 min, and then gluconic acid solution (8 mL) was added to the reaction mixture. The reaction mixture was stirred under N2 atmosphere at 80 °C for 8 h. Then, the final product was separated by magnetic decantation and washed with ethanol to remove the unattached substrate. The nanoparticle product (GA@MNPs) was dried at room temperature.

4.3. Preparation of supported glucosulfonic acid on Fe3O4 magnetic nanoparticles (GSA@MNPs)

The GA@MNPs (0.5 g) were dispersed in dry n-hexane (5 mL) using an ultrasonic bath for 20 min. Subsequently, chlorosulfonic acid (1.2 mL) was added drop-wise over a period of 30 min and the mixture was stirred for 4 h at room temperature. Then, the final product was separated by magnetic decantation and washed twice with dry n-hexane, ethanol and n-hexane, respectively, to remove the unattached substrate. The product (GSA@MNPs) was stored in a refrigerator prior to use.

4.4. General procedure for the synthesis of polyhydroquinoline derivatives

A mixture of aldehyde (1 mmol), dimedone (1 mmol), ethylacetoacetate (1 mmol), ammonium acetate (1.2 mmol) and GSA@MNPs (0.05 g) was stirred in ethanol under reflux conditions and the progress of the reaction was monitored by TLC. After completion of the reaction, the catalyst was separated using an external magnet and washed with ethyl acetate. Then, the solvent was evaporated and the product recrystallized in ethanol, from which the pure polyhydroquinoline derivatives were obtained in good to excellent yields.

4.5. General procedure for the synthesis of 2,3-dihydroquinazolin-4(1H)-ones derivatives

A mixture of GSA@MNPs (0.01 g), anthranilamide (1 mmol) and aldehyde (1 mmol) was stirred at 80 °C in ethanol (2 mL). The progress was monitored by TLC. After completion of the reaction, the reaction mixture was cooled to room temperature. CH2Cl2 (2 × 5 mL) was added and the catalyst was separated using an external magnet. CH2Cl2 was evaporated under reduced pressure to afford the essentially pure products and all products were recrystallized in ethanol for further purification.

4.6. Characterization data of selected compounds

Ethyl-4-(4-ethoxyphenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate (entry 2, Table 2). Mp: 176–179 °C. IR (KBr) cm−1: 3446, 3276, 3198, 1684, 1607, 1494. 1H NMR (400 MHz, DMSO-d6): δH = 7.28–7.19 (m, 2H), 6.74–6.72 (d, J = 8, 2H), 5.80 (s, 1H), 4.99 (s, 1H), 4.07–4.05 (t, J = 4, 2H), 3.97–3.96 (t, J = 3.6, 2H), 2.39–2.15 (m, 7H), 1.38–1.37 (m, 3H), 1.21–1.20 (m, 3H), 1.07 (s, 3H), 0.95 (s, 3H) ppm.
Ethyl-4-(4-methylphenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate (entry 3, Table 2). Mp: 252–254 °C. IR (KBr) cm−1: 3276, 3276, 3246, 3208, 1702, 1648, 1423. 1H NMR (400 MHz, DMSO-d6): δH = 9.04 (s, 1H), 7.05–7.03 (d, J = 8, 2H), 7.00–6.98 (d, J = 8, 2H), 4.82 (s, 1H), 4.00–3.95 (q, J = 7.2, 2H), 2.45–2.41 (d, J = 16, 1H), 2.31–2.27 (m, 4H), 2.21–2.15 (m, 4H), 2.10–1.96 (d, J = 16, 1H), 1.17–1.13 (t, J = 6.8, 3H), 1.02 (s, 3H), 0.86 (s, 3H) ppm.
Ethyl-4-(4-methoxyphenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate (entry 5, Table 2). Mp: 249–250 °C. IR (KBr) cm−1: 3278, 3246, 3208, 1701, 1649, 1423. 1H NMR (400 MHz, DMSO-d6): δH = 9.04 (s, 1H), 7.08–7.06 (d, J = 8.4, 2H), 6.77–6.75 (d, J = 8.4, 2H), 4.80 (s, 1H), 4.02–3.96 (q, J = 7.2, 2H), 3.69 (s, 3H), 2.52–2.45 (d, J = 29.2, 1H), 2.31–2.29 (m, 4H), 2.20–2.16 (d, J = 16, 1H), 2.01–1.97 (d, J = 16.4, 1H), 1.17–1.14 (t, J = 7.2, 3H), 1.02 (s, 3H), 0.87 (s, 3H) ppm.
Ethyl-4-(3,4-dimethoxyphenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate (entry 6, Table 2). Mp: 204–205 °C. IR (KBr) cm−1: 3280, 3213, 1696, 1645, 1452. 1H NMR (400 MHz, DMSO-d6): δH = 9.05 (s, 1H), 6.79–6.76 (m, 2H), 6.65–6.63 (d, J = 8, 1H), 4.80 (s, 1H), 4.04–3.99 (q, J = 7.2, 2H), 3.69–3.68 (d, J = 4.4, 5H), 2.47–2.42 (d, J = 17.2, 2H), 2.35–2.27 (m, 4H), 2.22–2.18 (d, J = 16, 1H), 2.03–1.99 (d, J = 16, 1H), 1.20–1.16 (t, J = 6.8, 3H), 1.03 (s, 3H), 0.90 (s, 3H) ppm.
Ethyl-4-(4-bromophenyl)-2,7,7-trimethyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline-3-carboxylate (entry 8, Table 2). Mp: 251–252 °C. IR (KBr) cm−1: 3276, 3243, 3207, 1703, 1649, 1421. 1H NMR (400 MHz, DMSO-d6): δH = 9.14 (s, 1H), 7.41–7.39 (d, J = 8.4, 2H), 7.13–7.11 (d, J = 8, 2H), 4.84 (s, 1H), 4.01–3.96 (q, J = 6.8, 2H), 2.52–2.46 (d, J = 26.4 1H), 2.31–2.27 (m, 4H), 2.21–2.17 (d, J = 16, 1H), 2.01–1.97 (d, J = 16, 1H), 1.15–1.12 (t, J = 7.2, 3H), 1.02 (s, 3H), 0.85 (s, 3H) ppm.
2-(4-Methylphenyl)-2,3-dihydroquinazolin-4(1H)-one (entry 4, Table 4). Mp: 228–230 °C. IR (KBr) cm−1: 3313, 1658, 1611, 1439. 1H NMR (400 MHz, DMSO-d6): δH = 8.21 (s, 1H), 7.62–7.59 (d, J = 7.5, 1H), 7.38–7.35 (d, J = 7.5, 2H), 7.26–7.14 (m, 3H), 7.03 (s, 1H), 6.75–6.64 (m, 2H), 5.71 (s, 1H), 2.49–2.42 (s, 3H) ppm.
2-(4-Ethoxyphenyl)-2,3-dihydoquinazolin-4(1H)-one (entry 5, Table 4). Mp: 167–169 °C. IR (KBr) cm−1: 3301, 1650, 1613, 1443. 1H NMR (400 MHz, DMSO-d6): δH = 7.95–7.94 (b, 1H), 7.52–7.50 (m, 2H), 7.34 (s, 1H), 7.26 (s, 1H), 6.95–6.90 (m, 3H), 6.68–6.67 (m, 1H), 5.85 (s, 1H), 5.75 (s, 1H), 4.07–4.05 (q, J = 4, 2H), 1.46–1.44 (s, 3H) ppm.
2-(3,4-Dimethoxyphenyl)-2,3-dihydoquinazolin-4(1H)-one (entry 6, Table 4). Mp: 211–213 °C. IR (KBr) cm−1: 3335, 1671, 1610, 1436. 1H NMR (400 MHz, DMSO-d6): δH = 8.21 (s, 1H), 7.64–7.62 (d, J = 7.6, 1H), 7.28–7.24 (t, J = 0.8, 1H), 7.15 (d, J = 1.6, 1H), 7.04–6.97 (m, 2H), 6.95 (s, 1H), 6.78–6.76 (d, J = 8, 1H), 6.72–6.67 (t, J = 1.2, 1H), 5.71 (s, 1H), 3.77 (s, 3H), 3.76 (s, 3H) ppm.
2-(4-Bromophenyl)-2,3-dihydoquinazolin-4(1H)-one (entry 8, Table 4). Mp: 197–199 °C. IR (KBr) cm−1: 3310, 1656, 1608, 1433. 1H NMR (400 MHz, DMSO-d6): δH = 8.17–8.14 (m, 1H), 7.80–7.78 (m, 1H), 7.63–7.59 (m, 3H), 7.47–7.44 (m, 2H), 7.30–7.24 (m, 1H), 6.77–6.72 (d, J = 19.2, 1H), 6.71–6.68 (m, 1H), 5.76 (s, 1H) ppm.
2-(4-Chlorophenyl)-2,3-dihydoquinazolin-4(1H)-one (entry 9, Table 4). Mp: 202–204 °C. IR (KBr) cm−1: 3309, 1655, 1611, 1435. 1H NMR (400 MHz, DMSO-d6): δH = 8.29 (s, 1H), 7.61–7.43 (m, 5H), 7.26–7.20 (t, J = 7.5, 1H), 7.12 (s, 1H), 6.75–6.63 (m, 2H), 5.75 (s, 1H) ppm.
2-(2-Nitrophenyl)-2,3-dihydoquinazolin-4(1H)-one (entry 10, Table 4). Mp: 190–192 °C. IR (KBr) cm−1: 3372, 1667, 1613, 1517, 1453, 1342. 1H NMR (400 MHz, DMSO-d6): δH = 8.26 (s, 1H), 8.10–8.08 (d, J = 8, 1H), 7.89–7.87 (d, J = 8, 1H), 7.83–7.80 (t, J = 0.8, 1H), 7.70–7.63 (m, 2H), 7.30–7.26 (m, 1H), 7.04 (s, 1H), 6.81 (d, J = 1.2, 1H), 6.77–6.72 (m, 1H), 6.36 (m, 1H) ppm.

Acknowledgements

This work was supported by the research facilities of Ilam University, Ilam, Iran.

Notes and references

  1. V. Polshettiwar, R. Luque, A. Fihri, H. Zhu, M. Bouhrara and J. M. Basset, Chem. Rev., 2011, 111, 3036 CrossRef CAS PubMed.
  2. S. Shylesh, V. Schunemann and W. R. Thiel, Angew. Chem., Int. Ed., 2010, 49, 3428 CrossRef CAS PubMed.
  3. F. Shahbazi and K. Amani, Catal. Commun., 2014, 55, 57 CrossRef CAS PubMed.
  4. A. Ghorbani-Choghamarani and M. Norouzi, J. Mol. Catal. A: Chem., 2014, 395, 172 CrossRef CAS PubMed.
  5. J. Govan and Y. K. Gun’ko, Nanomaterials, 2014, 4, 222 CrossRef CAS PubMed.
  6. Y. Zhu, L. P. Stubbs, F. Ho, R. Liu, C. P. Ship, J. A. Maguire and N. S. Hosmane, ChemCatChem, 2010, 2, 365 CrossRef CAS PubMed.
  7. A. Rostami, B. Tahmasbi, F. Abedi and Z. Shokri, J. Mol. Catal. A: Chem., 2013, 378, 200 CrossRef CAS PubMed.
  8. R. B. N. Baig and R. S. Varma, Chem. Commun., 2013, 49, 752 RSC.
  9. A. Ghorbani-Choghamarani and G. Azadi, RSC Adv., 2015, 5, 9752 RSC.
  10. A. Rostami, B. Tahmasbi, H. Gholami and H. Taymorian, Chin. Chem. Lett., 2013, 24, 211 CrossRef CAS PubMed.
  11. B. Atashkar, A. Rostami and B. Tahmasbi, Catal. Sci. Technol., 2013, 3, 2140 CAS.
  12. J. K. Xu, F. F. Zhang, J. J. Sun, J. Sheng, F. Wang and M. Sun, Molecules, 2014, 19, 21506 CrossRef CAS PubMed.
  13. H. Chen and Y. Wang, Ceram. Int., 2002, 28, 541 CrossRef CAS.
  14. J. Strunk, W. C. Vining and A. T. Bell, J. Phys. Chem. C, 2010, 114, 16937 CAS.
  15. M. W. E. van den Berg, A. De Toni, M. Bandyopadhyay, H. Gies and W. Grünert, Appl. Catal., A, 2011, 391, 268 CrossRef CAS PubMed.
  16. A. S. Frey and O. Hinrichsen, Microporous Mesoporous Mater., 2012, 164, 164 CrossRef CAS PubMed.
  17. M. Sheykhana, L. Ma’mani, A. Ebrahimi and A. Heydari, J. Mol. Catal. A: Chem., 2011, 335, 253 CrossRef PubMed.
  18. R. K. Sharma, Y. Monga and A. Puri, J. Mol. Catal. A: Chem., 2014, 393, 84 CrossRef CAS PubMed.
  19. M. A. Zolfigol, V. Khakyzadeh, A. R. Moosavi-Zare, A. Rostami, A. Zare, N. Iranpoor, M. H. Beyzavi and R. Luque, Green Chem., 2013, 15, 2132 RSC.
  20. H. Naeimi and Z. Nazifi, J. Nanopart. Res., 2013, 15, 2026 CrossRef PubMed.
  21. L. C. Fidale, M. Nikolajski, T. Rudolph, S. Dutz, F. H. Schacher and T. Heinze, J. Colloid Interface Sci., 2013, 390, 25 CrossRef CAS PubMed.
  22. S. M. Sadeghzadeh and M. A. Nasseri, Catal. Today, 2013, 217, 80 CrossRef CAS PubMed.
  23. Y. Kong, R. Tan, L. Zhao and D. Yin, Green Chem., 2013, 15, 2422 RSC.
  24. B. Karimi and E. Farhangi, Chemistry, 2011, 17, 6056 CrossRef CAS PubMed.
  25. Q. M. Kainz, R. Linhardt, R. N. Grass, G. Vilé, J. Pérez-Ramírez, W. J. Stark and O. Reiser, Adv. Funct. Mater., 2014, 24, 2020 CrossRef CAS PubMed.
  26. S. M. Vahdat, F. Chekin, M. Hatami, M. Khavarpour, S. Baghery and Z. Roshan-Kouhi, Chin. J. Catal., 2013, 34, 758 CrossRef CAS.
  27. M. Nasr-Esfahani, S. J. Hoseini, M. Montazerozohori, R. Mehrabi and H. Nasrabadi, J. Mol. Catal. A: Chem., 2014, 382, 99 CrossRef CAS PubMed.
  28. B. H. Chen, J. T. Li and G. F. Chen, Ultrason. Sonochem., 2015, 23, 59 CrossRef CAS PubMed.
  29. N. B. Darvatkar, S. V. Bhilare, A. R. Deorukhkar, D. G. Raut and M. M. Salunkhe, Green Chem. Lett. Rev., 2010, 3, 301 CrossRef CAS PubMed.
  30. V. Kekkonen, N. Lafreniere, M. Ebara and A. Saito, J. Magn. Magn. Mater., 2009, 321, 1393 CrossRef CAS PubMed.
  31. M. Hajjami, F. Ghorbani and F. Bakhti, Appl. Catal., A, 2014, 470, 303 CrossRef CAS PubMed.
  32. X. N. Zhao, H. C. Hu, F. J. Zhang and Z. H. Zhang, Appl. Catal., A, 2014, 482, 258 CrossRef CAS PubMed.
  33. M. Z. Kassaee, H. Masrouri and F. Movahedi, Appl. Catal., A, 2011, 395, 28 CrossRef CAS PubMed.
  34. S. Sobhani, A. Pakdin Parizi and N. Razavi, Appl. Catal., A, 2011, 409–410, 162 CrossRef CAS PubMed.
  35. R. Surasani, D. Kalita, A. V. D. Rao, K. Yarbagi and K. B. Chandrasekhar, J. Fluorine Chem., 2012, 135, 91 CrossRef CAS PubMed.
  36. A. Davoodnia, M. Khashi and N. Tavakoli-Hoseini, Chin. J. Catal., 2013, 34, 1173 CrossRef CAS.
  37. P. N. Kalaria, S. P. Satasia and D. K. Raval, Eur. J. Med. Chem., 2014, 78, 207 CrossRef CAS PubMed.
  38. V. B. Labade, P. V. Shinde and M. S. Shingare, Tetrahedron Lett., 2013, 54, 5778 CrossRef CAS PubMed.
  39. M. Desroses and M. Scobie, New J. Chem., 2013, 37, 3595 RSC.
  40. H. R. Shaterian and M. Aghakhanizade, Res. Chem. Intermed., 2014, 40, 1655 CrossRef CAS PubMed.
  41. J. Chen, W. Su, H. Wu, M. Liu and C. Jin, Green Chem., 2007, 9, 972 RSC.
  42. J. Safari and S. Gandomi-Ravandi, C. R. Chim., 2013, 16, 1158 CrossRef CAS PubMed.
  43. Y. X. Zong, Y. Zhao, V. C. Luo, X. H. Yu, J. K. Wang and Y. Pan, Chin. Chem. Lett., 2010, 21, 778 CrossRef CAS PubMed.
  44. J. Wang, Y. Zong, R. Fu, Y. Niu, G. Yue and Z. Quan, Ultrason. Sonochem., 2014, 21, 29 CrossRef CAS PubMed.
  45. J. Wu, X. Du, J. Ma, Y. Zhang, Q. Shi, L. Luo, B. Song, S. Yang and D. Hu, Green Chem., 2014, 16, 3210 RSC.
  46. Q. S. Ding, J. L. Zhang, J. X. Chen, M. C. Liu, J. C. Ding and H. Y. Wu, J. Heterocycl. Chem., 2012, 49, 375 CrossRef CAS PubMed.

Footnote

Electronic supplementary information (ESI) available. See DOI: 10.1039/c5ra08952b

This journal is © The Royal Society of Chemistry 2015
Click here to see how this site uses Cookies. View our privacy policy here.